Sign In
Last checked at 
31 Dec 2024 07:05
For release: 07.05, 31 December 2024
EMV Capital plc
(EMVC or the Company)
Grant of Share Options
EMV Capital plc (AIM: EMVC), the deeptech and life sciences VC investment group, announces that it has granted a total of 345,000 new options (New Options) to subscribe for ordinary shares in the capital of the Company (Ordinary Shares) to its directors and a PDMR, as detailed below.
In line with the Company's remuneration policy, the Remuneration Committee has approved the award of the following New Options to the Executive Directors and a PDMR as referred to below in connection with their annual remuneration. In addition, the Company's Board has approved the award of the following New Options to its Non-Executive Directors.
Director | New Options | Total options held (including existing options) |
Dr Ilian Iliev, CEO | 120,000 | 685,656 |
Ed Hooper, Executive Director | 120,000 | 685,656 |
Dr Charles Spicer, Chair | 30,000 | 125,238 |
Dr Jonathan Robinson, Senior Independent Director | 30,000 | 99,610 |
Nick Salisbury, PDMR | 45,000 | 45,000 |
The New Options were granted under the EMV Capital Share Option Scheme, pursuant to which options over a total of 2,417,732 Ordinary Shares have now been granted (excluding lapsed options but including exercised options), representing approximately 8.71 per cent. of the Company's issued share capital. The maximum potential dilution arising from options awarded under the EMV Capital Share Option Scheme remains below the upper limit of 10 per cent. under the rules of the plan.
The New Options have an exercise price of 50 pence per share, which price is equal to the issue price for the Company's recent share issuance (announced 5 December 2024) and higher than the average of the closing market quotations for Ordinary Shares over the five dealing days prior to the date on which the New Options were granted (the latter being the minimum price that could have been set).
The New Options will vest as to one third on the date of grant, as to a further third on the first anniversary of the date of grant and as to the final third on the second anniversary of the date of grant. The New Options may not be exercised earlier than the third anniversary of the date of grant and lapse 10 years after the date of grant (if not sooner in accordance with the terms of the EMV Capital Share Option Scheme rules).
The FCA notification, made in accordance with the requirements of the EU Market Abuse Regulation, is appended below.
The person responsible for arranging the release of this announcement on behalf of the Company is Ed Hooper, Executive Director and General Counsel of the Company.
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE UK VERSION OF REGULATION (EU) NO 596/2014 WHICH IS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.
-Ends-
For more information, please contact: | |
EMV Capital plc | via Rosewood |
Ilian Iliev, CEO |
|
|
|
Panmure Liberum (UK) Limited (NOMAD and Broker) | +44 (0)20 7886 2500 |
Emma Earl / Will Goode / Freddy Crossley / Mark Rogers (Corporate Finance) |
|
Rupert Dearden (Corporate Broking) |
|
|
|
Rosewood (Financial PR) | +44 (0)20 7653 8702 |
John West / Llewellyn Angus / Lily Pearce |
|
About EMV Capital plc (EMVC)
EMV Capital plc, formerly known as NetScientific plc, is a deep tech and life sciences venture capital investment group with an international portfolio of high-growth companies.
With a strategic focus on generating superior returns for investors from the fast-growing sectors and technologies that will define our future; EMV Capital invests in, manages and strengthens early stage IP-rich companies.
EMV Capital holds both direct equity stakes and carried interest in its portfolio companies, creating an evergreen structure that supports extensive growth and value creation. EMV Capital's investment thesis is realised through these capital sources:
· capital-efficient investments through Group balance sheet;
· fund management of the Evergreen EIS and Martlet Capital Funds;
· syndicated investments leveraging its network of third-party investors.
EMV Capital's approach is characterised by its proactive management style, aiming to advance portfolio companies to critical value inflection points by actively engaging with them. Companies are supported through Board representation and the use of its Value Creation Services practice.
Headquartered in London, with a Cambridge presence and strong international links, EMV Capital is quoted on the AIM market of the London Stock Exchange.
For more information, visit www.emvcapital.com
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a) | Name | Dr Ilian Iliev | ||||
2 | Reason for the notification | |||||
a) | Position/status | Director | ||||
b)
| Initial notification /Amendment | Initial Notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | EMV Capital plc | ||||
b) | LEI | 213800N5WD46G1Y7I458 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument Identification code | Options over EMVC 5p Ordinary Shares
GB00BN4R5Q82 | ||||
b) | Nature of the transaction | Grant of options | ||||
c)
| Price(s) and volume(s)
|
| ||||
d)
| Aggregated information - Aggregated volume
- Price
| N/a | ||||
e)
| Date of the transaction | 30 December 2024 | ||||
f)
| Place of the transaction | UK AIM | ||||
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a) | Name | Ed Hooper | ||||
2 | Reason for the notification | |||||
a) | Position/status | Director | ||||
b)
| Initial notification /Amendment | Initial Notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | EMV Capital plc | ||||
b) | LEI | 213800N5WD46G1Y7I458 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument Identification code | Options over EMVC 5p Ordinary Shares
GB00BN4R5Q82 | ||||
b) | Nature of the transaction | Grant of options | ||||
c)
| Price(s) and volume(s)
|
| ||||
d)
| Aggregated information - Aggregated volume
- Price
| N/a | ||||
e)
| Date of the transaction | 30 December 2024 | ||||
f)
| Place of the transaction | UK AIM | ||||
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a) | Name | Dr Charles Spicer | ||||
2 | Reason for the notification | |||||
a) | Position/status | Director | ||||
b)
| Initial notification /Amendment | Initial Notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | EMV Capital plc | ||||
b) | LEI | 213800N5WD46G1Y7I458 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument Identification code | Options over EMVC 5p Ordinary Shares
GB00BN4R5Q82 | ||||
b) | Nature of the transaction | Grant of options | ||||
c)
| Price(s) and volume(s)
|
| ||||
d)
| Aggregated information - Aggregated volume
- Price
| N/a | ||||
e)
| Date of the transaction | 30 December 2024 | ||||
f)
| Place of the transaction | UK AIM | ||||
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a) | Name | Dr Jonathan Robinson | ||||
2 | Reason for the notification | |||||
a) | Position/status | Director | ||||
b)
| Initial notification /Amendment | Initial Notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | EMV Capital plc | ||||
b) | LEI | 213800N5WD46G1Y7I458 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument Identification code | Options over EMVC 5p Ordinary Shares
GB00BN4R5Q82 | ||||
b) | Nature of the transaction | Grant of options | ||||
c)
| Price(s) and volume(s)
|
| ||||
d)
| Aggregated information - Aggregated volume
- Price
| N/a | ||||
e)
| Date of the transaction | 30 December 2024 | ||||
f)
| Place of the transaction | UK AIM | ||||
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a) | Name | Nick Salisbury | ||||
2 | Reason for the notification | |||||
a) | Position/status | PDMR | ||||
b)
| Initial notification /Amendment | Initial Notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | EMV Capital plc | ||||
b) | LEI | 213800N5WD46G1Y7I458 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument Identification code | Options over EMVC 5p Ordinary Shares
GB00BN4R5Q82 | ||||
b) | Nature of the transaction | Grant of options | ||||
c)
| Price(s) and volume(s)
|
| ||||
d)
| Aggregated information - Aggregated volume
- Price
| N/a | ||||
e)
| Date of the transaction | 30 December 2024 | ||||
f)
| Place of the transaction | UK AIM | ||||
Follow the stocks
